Johnson & Johnson

Johnson & Johnson Announces Potential Coronavirus Vaccine

Johnson & Johnson has announced a $1 billion deal with the U.S. government to create enough manufacturing capacity for more than one billion doses...

Johnson & Johnson Forecasts Weak Annual Profit, Misses Revenue Estimates

Johnson & Johnson has forecast 2020 profit to fall below Wall Street estimates, adding that increased competition could somewhat limit growth in it...

J&J Says New Tests Show No Asbestos In Johnson's Baby Powder

Johnson & Johnson said on Tuesday that recent tests showed that Johnson's Baby Powder was free of asbestos, after US Food and Drug Administration i...

Big US Retailers Pull 22-Ounce J&J Baby Powder Off Shelves After Recall

Four major US retailers, including Walmart and Target Corp, are removing all 22-ounce bottles of Johnson & Johnson's baby powder from their stores,...

J&J Beats Profit Estimates On Pharma Strength, Raises Sales Outlook

Johnson & Johnson hiked its full-year operational sales forecast as strong demand for its cancer drugs Darzalex and Imbruvica helped it beat estima...

Johnson & Johnson Reports Q1 Sales Above Expectations

Johnson & Johnson beat quarterly profit estimates on Tuesday and raised its adjusted sales growth forecast for the year. The company said it exp...

Johnson & Johnson 2019 Revenue Forecast Misses Expectations

Johnson & Johnson on Tuesday forecast 2019 sales that fell short of analysts' estimates after reporting better-than- expected fourth-quarter profit...

Johnson & Johnson Edges Past Profit Estimates, Lifts Outlook

Johnson & Johnson has reported slightly better-than-expected quarterly profit, and pushed its full-year forecast higher. Overall sales for the B...

Subscribe Today

FMCG Giants Could Face Repercussions From US-Russia Sanctions: Analysis

Johnson & Johnson Quarterly Profit Beats Analysts' Estimates

Johnson & Johnson Quarterly Profit Boosted By Pharmaceutical Division

Analysis: J&J Baby Powder Litigation Takes New Focus With Asbestos Claims

J&J Is Said To Consider Sale Of Anti-Dandruff Shampoo Nizoral

Johnson & Johnson Loses $110 Million Verdict Over Talc Cancer-Link Claim

J&J's Weak First-Quarter Sales Show Why It Made A Megadeal

Page 2

Enjoy unlimited digital access for 30 days

Get exclusive access to the latest grocery retail & FMCG news, interviews with industry leading executives, and expert analysis on the trends shaping the sector today

Subscribe now

Enjoy unlimited digital access for 30 days

Claim this offer

Enjoy unlimited digital access for 30 days

Get exclusive access to the latest grocery retail & FMCG news, interviews with industry leading executives, and expert analysis on the trends shaping the sector today

Subscribe now

Enjoy unlimited digital access for 30 days

Claim this offer

Get the app today!